The Australian and New Zealand Cardio-Oncology Registry (ACOR) is calling for clinicians to refer children, adolescents and young adult survivors of childhood cancer to the registry and biobank. The registry aims to provide the infrastructure to systematically document the cancer therapy-related cardiac dysfunction (CTRCD) phenotype following exposure to chemotherapy and other cardiotoxic drugs. It will ...
Registry to focus on cardiotoxicity after childhood cancer
By Mardi Chapman
16 Jan 2020